Cytokinetics, Incorporated company logo
Cytokinetics, Incorporated logo

Cytokinetics, Incorporated (CYTK)

Summary

Current Price
As of today, CYTK price is $76.84, down -0.44% on
Current Price All-Time High
CYTK price is currently -30.30% below its historical high of $110.25 set on
Market Cap
CYTK current market cap is $11B, up +134.73% over the past 365 days
Revenue
CYTK current annual revenue is $88.04M, up +376.56% year-over-year
Next Earnings
The next earnings release for CYTK is on

Profile

Company profile for Cytokinetics, Incorporated (CYTK)
MetricValue
Full NameCytokinetics, Incorporated
TickerNASDAQ: CYTK
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CountryUnited States
IPO
IndexesNot included
Websitecytokinetics.com
Employees498

Key Metrics

Cytokinetics, Incorporated Key Details
MetricValueDate
Price$76.84
Price, 1D Change-0.44%
Market Cap$11B
-
PE Ratio-
Beta0.69
Revenue$88.04M
Revenue, 1Y Change+376.56%
EPS-$6.54
EPS, 1Y Change-24.14%

Chart

SUGGESTED SERIES
Cytokinetics, Incorporated chart

Events

Cytokinetics, Incorporated Events
MetricValueDate
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last Split1:6
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

CYTK Estimates
MetricValueDate
EPS-$6.54
EPS Estimate-$5.97N/A
EPS Est. Change+8.73%N/A
Revenue$88.04M
Revenue Estimate$150.29MN/A
Revenue Est. Change+70.70%N/A
Current Price$76.84
Price Target$106.00-
Price Tgt. Change+37.95%-

🔒 Log In To Unlock Full Data

EPS

CYTK EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
-$5.16-$5.26-1.98%
-$6.22-$6.54-5.04%
-$5.97N/A+8.73%
-$4.42N/A+32.31%
CYTK EPS reported versus estimate values chart

Revenue

CYTK revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$14.37M$18.47M+28.55%
$81.03M$88.04M+8.65%
$150.29MN/A+70.70%
$422.49MN/A+379.89%
CYTK revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

CYTK Performance
MetricValueDate
Price, 1Y+101.94%
Price, 3Y+133.27%
Market Cap, 1Y+134.73%
Market Cap, 3Y+238.04%
Revenue, 1Y+376.56%
Revenue, 3Y-6.92%
EPS, 1Y-24.14%
EPS, 3Y-50.94%

🔒 Log In To Unlock Full Data

Technicals

CYTK Technical Indicators
MetricValueDate
Current Price$76.84
SMA 200$69.20
SMA 50$79.58
EMA 200$69.09
EMA 50$77.65
MACD-$0.96
Beta0.69
ATR$2.58
14-Day RSI46.93
10-Day Volatility25.97%

Dividends

CYTK Dividends
MetricValueDate
-N/A
UpcomingN/AN/A
-
-
$0.00
0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

CYTK Income & Profitability
MetricValueDate
Revenue$88.04M
EPS-$6.54
Gross Profit$0.00
Gross Margin88.50%
Operating Income-$612.26M
Operating Margin-695.44%
Net Income-$784.96M
Net Margin-891.60%
EBITDA-$602.13M

🔒 Log In To Unlock Full Data

Financial Health

CYTK Financial Health
MetricValueDate
Debt To Equity-1.95
4.53
4.53
-
1
-1.11

Valuations

CYTK Valuations
MetricValueDate
PE Ratio-
157.86
-61.58
-15.51
-N/A

Balance Sheet

CYTK Balance Sheet
MetricValueDate
Book Value-$659.62M
$885.34M
$1.42B
$916.98M
$2.08B
$202.45M
Total Debt$1.28B
$60.29M
$22.34M

Expenses

CYTK Expenses
MetricValueDate
$872.99M
$612.26M
$10.13M
$0.00
$10.13M
$0.00
$0.00

Cash Flow

CYTK Cash Flow
MetricValueDate
-$510.01M
$16.67M
$524.46M
Capex$24.81M
-$534.82M

Recent analyst updates

CYTK Recent analyst updates
MetricValueDate
JP Morgan
Barclays
Truist Securities
RBC Capital
Needham
Citizens
RBC Capital
UBS
Mizuho
Needham

Analyst sentiment

Sentiment over the past month
CYTK analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
CYTK institutional ownership distribution chart
No data

Screeners with CYTK

FAQ

What is the ticker symbol for Cytokinetics, Incorporated?
The ticker symbol for Cytokinetics, Incorporated is NASDAQ:CYTK
Does Cytokinetics, Incorporated pay dividends?
No, Cytokinetics, Incorporated does not pay dividends
What sector is Cytokinetics, Incorporated in?
Cytokinetics, Incorporated is in the Healthcare sector
What industry is Cytokinetics, Incorporated in?
Cytokinetics, Incorporated is in the Biotechnology industry
What country is Cytokinetics, Incorporated based in?
Cytokinetics, Incorporated is headquartered in United States
When did Cytokinetics, Incorporated go public?
Cytokinetics, Incorporated initial public offering (IPO) was on April 26, 2004
Is Cytokinetics, Incorporated in the S&P 500?
No, Cytokinetics, Incorporated is not included in the S&P 500 index
Is Cytokinetics, Incorporated in the NASDAQ 100?
No, Cytokinetics, Incorporated is not included in the NASDAQ 100 index
Is Cytokinetics, Incorporated in the Dow Jones?
No, Cytokinetics, Incorporated is not included in the Dow Jones index
When was Cytokinetics, Incorporated last earnings report?
Cytokinetics, Incorporated's most recent earnings report was on August 6, 2026
When does Cytokinetics, Incorporated report earnings?
The next expected earnings date for Cytokinetics, Incorporated is November 5, 2026

Data Sources & References

  1. CYTK Official Website www.cytokinetics.com
  2. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1061983/000119312526076495/0001193125-26-076495-index.htm
  3. CYTK Profile on Yahoo Finance finance.yahoo.com/quote/CYTK
  4. CYTK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cytk